Panacea Biotec increases availability of life saving drug ‘Cilamin250 Capsules’ in India

03 Jan 2017 Evaluate

Panacea Biotec, India’s leading Biotechnology Company has increased availability of Life Saving Drug Cilamin250 (D-Penicillamine IP 250mg) Capsules used for treatment of Wilson’s disease in India. The production of its brand Cilamin 250 Capsules has increased due to the receipt of additional quantity of raw material. Cilamin 250 Capsule is used for treatment of Wilsons disease, Rheumatoid Arthritis and other conditions witnessed short supply in the market during the last few months due to non-availability of raw material D-Penicillamine in India.

Panacea Biotec had already released limited quantities on 9th of December 2016 to select stockiest all over India. Additional quantity has now been made available starting from 2nd January 2017 at different stockiest all over India. The company is in regular touch with Department of Pharmaceuticals, NPPA and Drug Controller General of India for facilitating regular supplies of Cilamin250 capsules in the market.

Panacea Biotec is the largest biotechnology company as well as among the top 50 pharmaceutical companies of India. The company has product portfolio that’s caters therapeutics areas like pain management, diabetes and cardiovascular management, renal disease management, osteoporosis management, anti-tubercular, gastro-intestinal.


Panacea Biotec Share Price

344.65 -0.10 (-0.03%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×